Serious pneumococcal infections are a major global health problem and are vaccine-preventable.

Serious pneumococcal infections are a major global health problem and are vaccine-preventable.

PneumoADIP Web-Based Survey 2005

Key Findings

Summer, 2005. PneumoADIP conducted a web-based survey during the summer in order to assess what the broad pneumococcal community thinks about childhood pneumococcal vaccine supply and financing. 90 respondents self-identified themselves as researchers, clinicians, working in industry, in technical agencies, in NGOs, or in other areas. Once again, thank you to the individuals who participated in this anonymous survey; your inputs are valuable in moving forward.

Key findings suggest that finding solution space among countries, industry, and donors for pneumococcal vaccine introduction is indeed feasible, although not without challenges.

  • 71% responded that multi-valent pneumococcal conjugate vaccines can be made affordable to developing countries
  • 70% responded that the cost of manufacturing multi-valent vaccines is higher than the willingness to pay
  • 77% responded that researchers can influence donors and policy makers in decisions about pneumococcal vaccine introduction
  • 74% responded that companies should make a profit on vaccines that are supplied to developing countries

<< Back to News from the Field

The Pneumococcal vaccines Accelerated Development and Introduction Plan is based
at Johns Hopkins Bloomberg School of Public Health and is funded by GAVI Alliance.